Schisandrin B induces apoptosis and cell cycle arrest of gallbladder cancer cells

Molecules

Volumn 19, Issue 9, 2014, Pages 13235-13250

  Xiang, Shan Shan ^a   Wang, Xu An ^a   Li, Huai Feng ^a   Shu, Yi Jun ^a   Bao, Run Fa ^a   Zhang, Fei ^a   Cao, Yang ^a   Ye, Yuan Yuan ^a   Weng, Hao ^a   Wu, Wen Guang ^a   Mu, Jia Sheng ^a   Wu, Xiang Song ^a   Li, Mao Lan ^a   Hu, Yun Ping ^a   Jiang, Lin ^a   Tan, Zhu Jun ^a   Lu, Wei ^a   Liu, Feng ^b   Liu, Ying Bin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; Gallbladder cancer; Schisandrin B

Indexed keywords

CYCLOOCTANE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGNAN; POLYCYCLIC HYDROCARBON; SCHIZANDRIN B; TUMOR PROTEIN;

ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL CYCLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG EFFECTS; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CYCLOOCTANES; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGNANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; NEOPLASM PROTEINS; NF-KAPPA B; POLYCYCLIC COMPOUNDS;

EID: 84908143390     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190913235     Document Type: Article

References (37)

1. Dong, P.; He, X. W.; Gu, J; Wu, W. G.; Li, M. L.; Yang, J. H.; Zhang, L.; Ding, Q. C.; Lu, J. H.; Mu, J. S.; et al. Vimentin significantly promoted gallbladder carcinoma metastasis. Chin. Med. J. 2011, 124, 4236-4244.
2. Li, M.; Shen, J; Wu., X.; Zhang, B.; Zhang, R.; Weng, H.; Ding, Q.; Tan, Z.; Gao, G.; Mu, J.; et al. Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Med. Oncol. 2013, 30, 587.
3. Tan, Z.; Zhang, S.; Li, M.; Wu, X.; Weng, H.; Ding, Q.; Cao, Y.; Bao, R.; Shu, Y.; Mu, J.; et al. Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein. Gene 2013, 528, 261-266.
4. Wang, J. W.; Peng, S. Y.; Li, J. T.; Wang, Y.; Zhang, Z. P.; Cheng, Y.; Cheng, D. Q.; Weng, W. H.; Wu, X. S.; Fei, X. Z.; et al. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 2009, 281, 71-81.
5. Tan, Z.; Li, M.; Wu, W.; Zhang, L.; Ding, Q.; Wu, X.; Mu, J.; Liu, Y. NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Mol. Cell. Biochem. 2012, 369, 27-33.
6. Wang, J. D.; Shi, W. B.; Shen, J.; Zhuang, P. Y.; Quan, Z. W.; Wang, X. F.; Zhou, X. P.; Li, S. G.; Liu, Y. B.; Yang, Y. Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer. Med. Oncol. 2011, 28, 295-300.
7. Wu, X. S.; Shi, L. B.; Li, M. L.; Ding, Q.; Weng, H.; Wu, W. G.; Cao, Y.; Bao, R. F.; Shu, Y. J.; Ding, Q. C.; et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann. Surg. Oncol. 2014, 21, 449-457.
8. Sharma, A.; Dwary, A. D.; Mohanti, B. K.; Deo, S. V.; Pal, S.; Sreenivas, V.; Raina, V.; Shukla, N. K.; Thulkar, S.; Garg, P.; et al. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: A randomized controlled study. J. Clin. Oncol. 2010, 28, 4581-4586.
9. Ducreux, M.; Rougier, P.; Fandi, A.; Clavero-Fabri, M. C.; Villing, A. L.; Fassone, F.; Fandi, L.; Zarba, J.; Armand, J. P. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann. Oncol. 1998, 9, 653-656.
10. Bartlett, D. L.; Fong, Y.; Fortner, J. G.; Brennan, M. F.; Blumgart, L. H. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann. Surg. 1996, 224, 639-646.
11. Butte, J. M.; Matsuo, K.; Gonen, M.; D'Angelica, M. I.; Waugh, E.; Allen, P. J.; Fong, Y.; DeMatteo, R. P.; Blumgart, L.; Endo, I.; et al. Gallbladder cancer: Differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J. Am. Coll. Surg. 2011, 212, 50-61.
12. Cziupka, K.; Partecke, L. I.; Mirow, L.; Heidecke, C. D.; Emde, C.; Hoffmann, W.; Siewert, U.; van den Berg, N.; von Bernstorff, W.; Stier, A. Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbeck's Arch. Surg. 2012, 397, 899-907.
13. Checker, R.; Patwardhan, R. S.; Sharma, D.; Menon, J.; Thoh, M.; Bhilwade, H. N.; Konishi, T.; Sandur, S. K. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free Radic. Biol. Med. 2012, 53, 1421-1430.
14. Liu, G. T. Pharmacological actions and clinical use of fructus schizandrae. Chin. Med. J. 1989, 102, 740-749.
15. Park, E. J.; Chun, J. N.; Kim, S. H.; Kim, C. Y.; Lee, H. J.; Kim, H. K.; Park, J. K.; Lee, S. W.; So, I.; Jeon, J. H. Schisandrin B suppresses TGFbeta1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem. Pharmacol. 2012, 83, 378-384.
16. Nishida, H.; Tatewaki, N.; Nakajima, Y.; Magara, T.; Ko, K. M.; Hamamori, Y.; Konishi, T. Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response. Nucleic Acids Res. 2009, 37, 5678-5689.
17. Liu, X. N.; Zhang, C. Y.; Jin, X. D.; Li, Y. Z.; Zheng, X. Z.; Li, L. Inhibitory effect of schisandrin B on gastric cancer cells in vitro. World J. Gastroenterol. 2007, 13, 6506-6511.
18. Sun, M.; Xu, X.; Lu, Q.; Pan, Q.; Hu, X. Schisandrin B: A Dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1. Cancer Lett. 2007, 246, 300-307.
19. Li, L.; Wang, T.; Xu, Z. L.; Yu, Y.; Chen, W.; Chen, F. Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene. Zhonghua Yi Xue Za Zhi 2005, 85, 1633-1637.
20. Qiangrong, P.; Wang, T.; Lu, Q.; Hu, X. Schisandrin B-A novel inhibitor of P-glycoprotein. Biochem. Biophys. Res. Commun. 2005, 335, 406-411.
21. Liu, Z.; Zhang, B.; Liu, K.; Ding, Z.; Hu, X. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS One 2012, 7, e40480.
22. Li, Y. Z.; Liu, Z. X.; Zhao, F. S.; Liang J. Effects of the different concentration schisandrin B inducing multiplication and apoptosis on human gastric cancer cell line mgc-803. J. Mudanjing Med. Univ. 2010, 31, 1-5.
23. Li, L; Lu, Q.; Shen, Y.; Hu, X. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem. Pharmacol. 2006, 71, 584-595.
24. Saris, N. E.; Teplova, V. V.; Odinokova, I. V.; Azarashvily, T. S. Interference of calmidazolium with measurement of mitochondrial membrane potential using the tetraphenylphosphonium electrode or the fluorescent probe rhodamine 123. Anal. Biochem. 2004, 328, 109-112.
25. Spencer, S. L.; Sorger, P. K. Measuring and modeling apoptosis in single cells. Cell 2011, 144, 926-939.
26. Rodriguez-Vargas, J. M.; Ruiz-Magana, M. J.; Ruiz-Ruiz, C.; Majuelos-Melguizo, J.; Peralta-Leal, A.; Rodriguez, M. I.; Munoz-Gamez, J. A.; de Almodovar, M. R.; Siles, E.; Rivas, A. L.; et al. ROS-induced DNA damage and PARP-1 are required for optimal induction of starvation-induced autophagy. Cell Res. 2012, 22, 1181-1198.
27. Lv, H.; Li, Y.; Du, H.; Fang, J.; Song, X.; Zhang, J. The Synthetic Compound Norcantharidin Induced Apoptosis in Mantle Cell Lymphoma in vivo and in vitro through the PI3K-Akt-NF-kappa B Signaling Pathway. Evid. Based Complement. Alternat. Med. 2013, 2013, 461-487.
28. She, E. X.; Hao, Z. A novel piperazine derivative potently induces caspase-dependent apoptosis of cancer cells via inhibition of multiple cancer signaling pathways. Am. J. Transl. Res. 2013, 5, 622-633.
29. Du, L.; Mei, H. F.; Yin, X.; Xing, Y. Q. Delayed growth of glioma by a polysaccharide from Aster tataricus involve upregulation of Bax/Bcl-2 ratio, activation of caspase-3/8/9, and downregulation of the Akt. Tumour Biol. 2014, 35, 1819-1825.
30. Mansoor, T. A.; Ramalho, R. M.; Luo, X.; Ramalhete, C.; Rodrigues, C. M.; Ferreira, M. J. Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. Phytother. Res. 2011, 25, 1819-1824.
31. Ngamkitidechakul, C.; Jaijoy, K.; Hansakul, P.; Soonthornchareonnon, N.; Sireeratawong, S. Antitumour effects of Phyllanthus emblica L.: Induction of cancer cell apoptosis and inhibition of in vivo tumour promotion and in vitro invasion of human cancer cells. Phytother. Res. 2010, 24, 1405-1413.
32. Korsmeyer, S. J.; Shutter, J. R.; Veis, D. J.; Merry, D. E.; Oltvai, Z. N. Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 1993, 4, 327-332.
33. Lindsay, J.; Esposti, M. D.; Gilmore, A. P. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochim. Biophys. Acta 2011, 1813, 532-539.
34. Saab, R.; Bills, J. L.; Miceli, A. P.; Anderson, C. M.; Khoury, J. D.; Fry, D. W.; Navid, F.; Houghton, P. J.; Skapek, S. X. Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol. Cancer Ther. 2006, 5, 1299-1308.
35. Marzec, M.; Kasprzycka, M.; Lai, R.; Gladden, A. B.; Wlodarski, P.; Tomczak, E.; Nowell, P.; Deprimo, S. E.; Sadis, S.; Eck, S.; et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006, 108, 1744-1750.
36. Zhan, S. Y.; Shao, Q.; Fan, X. H.; Li, Z.; Cheng, Y. Y. Tissue distribution and excretion of herbal components after intravenous administration of a Chinese medicine (Shengmai injection) in rat. Arch. Pharmacal Res. 2014, 36, 1259-1267.
37. Li, W. L.; Xin, H. W.; Yu, A. R.; Wu, X. C. In vivo effect of Schisandrin B on cytochrome P450 enzyme activity. Phytomedicine 2013, 20, 760-765.